Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
Saved in:
| Title: | Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry. |
|---|---|
| Authors: | Butzkueven H; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Spelman T; Department of Medicine and Melbourne Brain Centre, The Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia., Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Hughes S; Department of Neurology, Craigavon Area Hospital, Craigavon, UK.; Belfast Health and Social Care Trust, Belfast, UK., Solaro C; CRRF 'Mons. Luigi Novarese', Moncrivello, (VC), Italy., Izquierdo G; Vithas Nisa Hospital, Seville, Spain., Kubala Havrdová E; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University, Prague, Czech Republic., Grand'Maison F; Neuro Rive-Sud, Quebec City, Quebec, Canada., Prat A; CHUM and Universite de Montreal, Montreal, Quebec, Canada., Girard M; CHUM and Universite de Montreal, Montreal, Quebec, Canada., Hupperts R; Zuyderland Ziekenhuis, Sittard, The Netherlands., Onofrj M; University G. d'Annunzio, Chieti, Italy., Lugaresi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy.; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy., Taylor B; Royal Hobart Hospital, Hobart, Tasmania, Australia., Giovannoni G; Queen Mary University of London, London, UK., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center, University Hospital Basel and University of Basel, Basel, Switzerland., Hauser SL; University of California, San Francisco, California, USA., Montalban X; Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Craveiro L; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Freitas R; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Model F; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Overell J; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Muros-Le Rouzic E; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Sauter A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wang Q; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wormser D; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wolinsky JS; McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas, USA. |
| Corporate Authors: | MSBase Study Group |
| Source: | European journal of neurology [Eur J Neurol] 2022 Apr; Vol. 29 (4), pp. 1082-1090. Date of Electronic Publication: 2021 May 06. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1468-1331 |
|---|---|
| DOI: | 10.1111/ene.14824 |
